Kronos Bio Statistics
Total Valuation
III has a market cap or net worth of $242.91 million. The enterprise value is $279.87 million.
| Market Cap | 242.91M |
| Enterprise Value | 279.87M |
Important Dates
The last earnings date was Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | Sep 5, 2025 |
Share Statistics
III has 48.20 million shares outstanding. The number of shares has increased by 4.35% in one year.
| Current Share Class | 48.20M |
| Shares Outstanding | 48.20M |
| Shares Change (YoY) | +4.35% |
| Shares Change (QoQ) | -0.24% |
| Owned by Insiders (%) | 17.13% |
| Owned by Institutions (%) | 62.33% |
| Float | 34.23M |
Valuation Ratios
The trailing PE ratio is 32.12 and the forward PE ratio is 15.27. III's PEG ratio is 0.85.
| PE Ratio | 32.12 |
| Forward PE | 15.27 |
| PS Ratio | 1.02 |
| Forward PS | 1.31 |
| PB Ratio | 2.59 |
| P/TBV Ratio | 66.81 |
| P/FCF Ratio | 9.47 |
| P/OCF Ratio | 8.60 |
| PEG Ratio | 0.85 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 15.93, with an EV/FCF ratio of 10.91.
| EV / Earnings | 35.60 |
| EV / Sales | 1.17 |
| EV / EBITDA | 15.93 |
| EV / EBIT | 22.32 |
| EV / FCF | 10.91 |
Financial Position
The company has a current ratio of 2.43, with a Debt / Equity ratio of 0.66.
| Current Ratio | 2.43 |
| Quick Ratio | 2.25 |
| Debt / Equity | 0.66 |
| Debt / EBITDA | 3.02 |
| Debt / FCF | 2.42 |
| Interest Coverage | 2.57 |
Financial Efficiency
Return on equity (ROE) is 8.29% and return on invested capital (ROIC) is 4.75%.
| Return on Equity (ROE) | 8.29% |
| Return on Assets (ROA) | 3.59% |
| Return on Invested Capital (ROIC) | 4.75% |
| Return on Capital Employed (ROCE) | 7.68% |
| Revenue Per Employee | $181,558 |
| Profits Per Employee | $5,942 |
| Employee Count | 1,323 |
| Asset Turnover | 1.10 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, III has paid $4.63 million in taxes.
| Income Tax | 4.63M |
| Effective Tax Rate | 37.05% |
Stock Price Statistics
The stock price has increased by +60.00% in the last 52 weeks. The beta is 1.25, so III's price volatility has been higher than the market average.
| Beta (5Y) | 1.25 |
| 52-Week Price Change | +60.00% |
| 50-Day Moving Average | 4.69 |
| 200-Day Moving Average | 3.84 |
| Relative Strength Index (RSI) | 66.11 |
| Average Volume (20 Days) | 281,885 |
Short Selling Information
The latest short interest is 254,228, so 0.53% of the outstanding shares have been sold short.
| Short Interest | 254,228 |
| Short Previous Month | 235,053 |
| Short % of Shares Out | 0.53% |
| Short % of Float | 0.74% |
| Short Ratio (days to cover) | 1.10 |
Income Statement
In the last 12 months, III had revenue of $240.20 million and earned $7.86 million in profits. Earnings per share was $0.16.
| Revenue | 240.20M |
| Gross Profit | 100.33M |
| Operating Income | 12.54M |
| Pretax Income | -1.46M |
| Net Income | 7.86M |
| EBITDA | 17.57M |
| EBIT | 12.54M |
| Earnings Per Share (EPS) | $0.16 |
Balance Sheet
The company has $25.22 million in cash and $62.19 million in debt, giving a net cash position of -$36.97 million or -$0.77 per share.
| Cash & Cash Equivalents | 25.22M |
| Total Debt | 62.19M |
| Net Cash | -36.97M |
| Net Cash Per Share | -$0.77 |
| Equity (Book Value) | 94.10M |
| Book Value Per Share | 1.95 |
| Working Capital | 53.43M |
Cash Flow
In the last 12 months, operating cash flow was $28.25 million and capital expenditures -$2.60 million, giving a free cash flow of $25.65 million.
| Operating Cash Flow | 28.25M |
| Capital Expenditures | -2.60M |
| Free Cash Flow | 25.65M |
| FCF Per Share | $0.53 |
Margins
Gross margin is 41.77%, with operating and profit margins of 5.22% and 3.27%.
| Gross Margin | 41.77% |
| Operating Margin | 5.22% |
| Pretax Margin | 5.20% |
| Profit Margin | 3.27% |
| EBITDA Margin | 7.31% |
| EBIT Margin | 5.22% |
| FCF Margin | 10.68% |
Dividends & Yields
This stock pays an annual dividend of $0.18, which amounts to a dividend yield of 3.57%.
| Dividend Per Share | $0.18 |
| Dividend Yield | 3.57% |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | 3 |
| Payout Ratio | 114.70% |
| Buyback Yield | -4.35% |
| Shareholder Yield | -0.78% |
| Earnings Yield | 3.24% |
| FCF Yield | 10.56% |
Analyst Forecast
The average price target for III is $5.50, which is 9.13% higher than the current price. The consensus rating is "Buy".
| Price Target | $5.50 |
| Price Target Difference | 9.13% |
| Analyst Consensus | Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
III has an Altman Z-Score of 2.02 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 2.02 |
| Piotroski F-Score | 7 |